Literature DB >> 8439969

Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

A Yanagisawa1, K Ohtake, K Ohashi, M Hori, T Kitagawa, H Sugano, Y Kato.   

Abstract

In order to scrutinize the possible significance of (nonatypical) mucous cell hyperplasia of the pancreas to neoplasia, we analyzed these lesions in terms of c-Ki-ras activation, which is known to be very frequent in pancreatic carcinomas. A total of 16 such mucous cell hyperplasias were collected from 10 pancreases resected for chronic pancreatitis. Tiny tissue fragments were taken from hematoxylin-stained sections by microdissection, and DNA analysis was carried out by the polymerase chain reaction amplification and oligonucleotide hybridization methods. Activating mutations of c-Ki-ras oncogene at codon 12 were detected in 10 of the 16 lesions (62.5%), a high rate as seen in carcinomas. The results indicated a clonal origin of cells comprising the mucous cell hyperplasia suggesting a neoplastic and/or precancerous nature.

Entities:  

Mesh:

Year:  1993        PMID: 8439969

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  81 in total

1.  Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections.

Authors:  J Serth; M A Kuczyk; U Paeslack; R Lichtinghagen; U Jonas
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Genetic progression in the pancreatic ducts.

Authors:  R H Hruban; R E Wilentz; S E Kern
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 3.  Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures.

Authors:  T M Gress
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

4.  A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma.

Authors:  Eric A Collisson; Christy L Trejo; Jillian M Silva; Shenda Gu; James E Korkola; Laura M Heiser; Roch-Philippe Charles; Brian A Rabinovich; Byron Hann; David Dankort; Paul T Spellman; Wayne A Phillips; Joe W Gray; Martin McMahon
Journal:  Cancer Discov       Date:  2012-05-24       Impact factor: 39.397

5.  K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers.

Authors:  K Sugio; K Molberg; J Albores-Saavedra; A K Virmani; Y Kishimoto; A F Gazdar
Journal:  Int J Pancreatol       Date:  1997-06

6.  Is there a causal relation between pancreas divisum and pancreatic cancer?

Authors:  Terumi Kamisawa
Journal:  J Gastroenterol       Date:  2006-11       Impact factor: 7.527

Review 7.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

8.  Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.

Authors:  S T Dergham; M C Dugan; R Kucway; W Du; D S Kamarauskiene; V K Vaitkevicius; J D Crissman; F H Sarkar
Journal:  Int J Pancreatol       Date:  1997-04

9.  High frequency of K-ras mutations in human colorectal hyperplastic polyps.

Authors:  K Otori; Y Oda; K Sugiyama; T Hasebe; K Mukai; T Fujii; H Tajiri; S Yoshida; S Fukushima; H Esumi
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 10.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.